EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report

Niki Armstrong, Susan Apkon, Kiera N Berggren, Catherine Braun, Emma Ciafaloni, Anne Connolly, Annie Kennedy, Nancy Kuntz, Katherine Mathews, Michelle McGuire, Richard Parad, Mena Scavina und 2 weitere

Journal of Neuromuscular Diseases · 05.03.2024 · 11 (2) · 525-533

DOI: 10.3233/jnd-230180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 04.01.2024. Verfasst von Niki Armstrong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Parent Project Muscular Dystrophy, Washington, DC, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This report summarizes the key discussions from the “Early Care (0–3 years) in Duchenne Muscular Dystrophy” meeting, which aimed to address the challenges and opportunities in the diagnosis and care of Duchenne muscular dystrophy (DMD) and female carriers within the 0–3-year age group.

Methods

The meeting brought together experts and healthcare providers who shared insights, discussed advancements in DMD care, and identified research needs. Presentations covered diagnostic challenges, approved therapies, clinical trials, identification of young female carriers, and the importance of clinical care and support for families.

Results

The meeting highlighted the importance of timely diagnosis and the lack of evidence-based guidelines for the care of children with DMD aged 0–3 years. Diagnostic challenges were discussed, including delays in receiving a DMD diagnosis and disparities based on ethnicity. The potential benefits and process of newborn screening were addressed. Approved therapeutic interventions, such as corticosteroids and exon-skipping drugs, were explored, with studies indicating the potential benefits of early initiation of corticosteroid therapy and the safety of exon-skipping drugs in DMD. Clinical trials involving infants and young boys were discussed, focusing on drugs like ataluren, vamorolone, and gene therapies. The meeting emphasized the importance of clinical care and support for families, including comprehensive information provision, early intervention services, and individualized support. The identification and care of young female carriers were also addressed.

Conclusion

The meeting provided a platform for experts and healthcare providers to discuss and identify key aspects of early care for children with DMD aged 0–3 years. The meeting emphasized the need for early diagnosis, evidence-based guidelines, and comprehensive care and support for affected children and their families. Further research, collaboration, and the development of consensus guidelines are needed to improve early diagnosis, treatment, and outcomes in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneChild, PreschoolFemaleHumansInfantInfant, NewbornMaleAdrenal Cortex HormonesNeonatal Screening

Stichwörter der Autor:innen

Duchenne muscular dystrophygenetic carrier screeninggenetic counselinggenetic testingneurodevelopmental disordersneuromuscular diseases –diagnosisnewborn screeningpatient care managementtherapeutics

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Parent Project Muscular Dystrophy, Washington, DC, USA.
  • Children's Hospital Colorado/University of Colorado, Aurora, CO, USA.
  • Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA.
  • University of Virginia Children's Hospital, Charlottesville, VA, USA.
  • University of Rochester, , Rochester, NY, USA.
  • Nationwide Children's Hospital, Columbus, OH, USA.

Zitieren

APA

Armstrong, N., Apkon, S., Berggren, K. N., Braun, C., Ciafaloni, E., Connolly, A., Kennedy, A., Kuntz, N., Mathews, K., McGuire, M., Parad, R., Scavina, M., Scharf, R. J., & Waldrop, M. (2024). The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report. Journal of Neuromuscular Diseases, 11(2), 525-533. https://doi.org/10.3233/jnd-230180

Vancouver

Armstrong N, Apkon S, Berggren KN, Braun C, Ciafaloni E, Connolly A, et al. The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report. Journal of Neuromuscular Diseases. 2024;11(2):525-533. doi:10.3233/jnd-230180

BibTeX
@article{Armstrong2024,
  author = {Armstrong, Niki and Apkon, Susan and Berggren, Kiera N and Braun, Catherine and Ciafaloni, Emma and Connolly, Anne and Kennedy, Annie and Kuntz, Nancy and Mathews, Katherine and McGuire, Michelle and Parad, Richard and Scavina, Mena and Scharf, Rebecca J and Waldrop, Megan},
  title = {The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report},
  journal = {Journal of Neuromuscular Diseases},
  year = {2024},
  volume = {11},
  number = {2},
  pages = {525--533},
  doi = {10.3233/jnd-230180}
}
Kostenlos starten →